MEDFORD, Mass., May 15, 2017 /PRNewswire/ — INVO Bioscience, Inc. (OTC: IVOB), a medical device company who was granted FDA clearance for the first Intravaginal Culture System, INVOcell™, today announced its first quarter financial results and recent highlights.
Recent Highlights…
May 16, 2017 at 01:30AM
from
No comments:
Post a Comment